Modified Nuclear Phacoemulsification in Brown Cataract

NCT ID: NCT07252154

Last Updated: 2025-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-01

Study Completion Date

2025-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Irrigation of the nucleus with saline for 30 seconds after creating the central groove.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The hard nucleus is physiologically immune against water flow from out to inside the nucleus but we discovered that it is not immune against the flow of water from inside the nucleus to outside. So, we are doing phacoemulsification as usual, but we stop when the gutter becomes half the thickness of the nucleus, then we use the tip of the phaco as irrigation for 30 seconds. the nucleus will become softer.

. As we know, the nucleus of the lens has the highest concentration of crystalline (high osmotic pressure), so the water will flow from the center of the nucleus to the outer surface without any resistance, and all adhesions and bonds between lens fibers will be broken at once, and the nucleus becomes softer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brown Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Brown cataract

doing phacoemulsification as usual, but we stop when the gutter becomes half the thickness of the nucleus, then we use the tip of the phaco as irrigation for 30 seconds. the nucleus will become softer

Group Type EXPERIMENTAL

phacoemulsification

Intervention Type PROCEDURE

doing phacoemulsification as usual but we stop when the gutter becomes half the thickness of the nucleus then we use tip of the phaco as irrigation for 30 seconds. the nucleus will become more softer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phacoemulsification

doing phacoemulsification as usual but we stop when the gutter becomes half the thickness of the nucleus then we use tip of the phaco as irrigation for 30 seconds. the nucleus will become more softer

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Brown cataract

Exclusion Criteria

* white cataract
* soft cataract
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hassan Lotfy Fahmy

Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut univercity

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17209067

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.